Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.65 USD | +4.05% | -8.20% | -14.92% |
05-14 | Citius Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
04-26 | Citius Pharmaceuticals Launches $15 Million Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.92% | 113M | |
+31.61% | 49.46B | |
+1.01% | 42.58B | |
+48.88% | 42.49B | |
-5.26% | 29.09B | |
+12.48% | 26.61B | |
-23.61% | 18.64B | |
+7.22% | 13.16B | |
+30.84% | 12.55B | |
+23.68% | 12.1B |
- Stock Market
- Equities
- CTXR Stock
- News Citius Pharmaceuticals, Inc.
- Citius Pharmaceuticals Says No Additional Trials Required to Support Biologics License Application for Lymphir